New AI tool can help select the most suitable treatment for cancer patients

A new artificial intelligence (AI) tool that can help to select the most suitable treatment for cancer patients has been developed by researchers at The Australian National University (ANU).

DeepPT, developed in collaboration with scientists at the National Cancer Institute in America and pharmaceutical company Pangea Biomed, works by predicting a patient's messenger RNA (mRNA) profile. This mRNA - essential for protein production - is also the key molecular information for personalised cancer medicine. 

According to lead author Dr Danh-Tai Hoang from ANU, when combined with a second tool called ENLIGHT, DeepPT was found to successfully predict a patient's response to cancer therapies across multiple types of cancer. 

We know that selecting a suitable treatment for cancer patients can be integral to patient outcomes.

DeepPT was trained on over 5,500 patients across 16 prevalent cancer types, including breast, lung, head and neck, cervical and pancreatic cancers.

We saw an improvement in patient response rate from 33.3 per cent without using our model to 46.5 per cent with using our model." 

Dr. Danh-Tai Hoang from ANU

DeepPT builds on previous work by the same ANU researchers to develop a tool to help classify brain tumors.

Both AI tools draw on microscopic pictures of patient tissue called histopathology images, also providing another key benefit for patients. 

"This cuts down on delays in processing complex molecular data, which can take weeks," Dr Hoang said. 

"Any kind of delay obviously poses a real challenge when dealing with patients with high-grade tumors who might require immediate treatment. 

"In contrast, histopathology images are routinely available, cost-effective and timely." 

The study has been published in Nature Cancer. 

Journal reference:

Hoang, D.-T., et al. (2024). A deep-learning framework to predict cancer treatment response from histopathology images through imputed transcriptomics. Nature Cancer.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study: Women with severe endometriosis 10 times more likely to get ovarian cancer